drugset / Trial / NCT03900624

Ideal Steroids for Asthma Treatment in the PICU

NCT03900624 ↗

Phase 4 Completed 92 enrolled Johns Hopkins All Children's Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Determine if differences in (1) pediatric intensive care unit length of stay, (2) continuous nebulized albuterol duration, and (3) a composite outcome of advanced asthma therapy incidence including use of non-invasive ventilation (NIV), terbutaline, inhaled helium and mechanical ventilation between cohorts of children admitted with status asthmaticus to the PICU treated with either IV dexamethasone (DM) or methylprednisolone (MP).

Timeline

Start
2019-04-21
Primary completion
2021-12-31
Completion
2022-05-15

Outcome

Missed primary endpoint

registry analysis (superiority test); Methylprednisolone Arm - Standard Care vs Dexamethasone Arm - Interventional Arm; p = 0.632; Wilcoxon (Mann-Whitney) NCT03900624 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule — Intravenous